Inotropes and Vasopressors | Circulation - AHA/ASA Journals
网页2008年9月2日 · Inotropes and vasopressors are used routinely in the setting of cardiogenic shock complicating acute myocardial infarction (AMI). These agents all increase myocardial oxygen consumption and can cause ventricular arrhythmias, contraction-band necrosis, and infarct expansion.
Use of vasopressors and inotropes - UpToDate
网页2023年12月8日 · Vasopressors are a powerful class of drugs that induce vasoconstriction and thereby elevate mean arterial pressure (MAP). Vasopressors differ from inotropes, which increase cardiac contractility; however, many drugs have both vasopressor and inotropic effects.
网页Common vasopressors and inotropes . The table outlines clinical indications, associated receptors, physiology, dosing, titration rates, and adverse effects of various vasopressors and inotropes.*
Inotropes and Vasopressors - StatPearls - NCBI Bookshelf
网页2023年2月19日 · This activity describes the mode of action of inotropes and vasopressors, including mechanism of action, pharmacology, adverse event profiles, eligible patient populations, and monitoring, and highlights the role of the interprofessional team in the management of conditions where vasopressors and inotropes.
Inotropes and Vasopressors: Doses, indications, …
网页Inotropes and vasopressors. Vasopressors induce vasoconstriction and increase mean arterial pressure (MAP). Inotropes increase cardiac contractile force (contractility). Several endogenous and synthetic agents exist and are frequently combined to achieve the desired hemodynamic outcome.
Inotropes, vasopressors and other vasoactive agents
网页2020年11月3日 · inotropes are agents that increase myocardial contractility (inotropy) — e.g. adrenaline, dobutamine, isoprenaline, ephedrine. vasopressors are agents that cause vasoconstriction leading to increased systemic and/or pulmonary vascular resistance (SVR, PVR) — e.g. noradrenaline, vasopressin, metaraminol, vasopressin, methylene blue.
网页Inotropes and Vasopressors. Review of Physiology and Clinical Use in Cardiovascular Disease. Christopher B. Overgaard, MD; Vladimír Dzˇavík, MD. Inotropic and vasopressor agents have increasingly become a therapeutic cornerstone for the management of several important cardiovascular syndromes.
网页catecholamine vasopressors and inotropes –Vasopressin’s effects are preserved •Hypocalcemia may lead to inadequate response –Replete patients with hypocalcemia –Consider empiric calcium in patients receiving multiple blood transfusions
Inotropes and Vasopressors - PubMed
网页2023年2月19日 · This activity describes the mode of action of inotropes and vasopressors, including mechanism of action, pharmacology, adverse event profiles, eligible patient populations, and monitoring, and highlights the role of the interprofessional team in the management of conditions where vasopressors and inotropes.
Chapter 20: Pharmacology of Vasopressors and Inotropes
网页Most vasopressors have multiple actions on the heart and vasculature and have a propensity to cause arrhythmias. Some vasopressors are also inotropes and are used to improve cardiac output, particularly in patients with left ventricular pump failure or cardiogenic shock.
- 某些结果已被删除